Reduced progression of atherosclerosis in apolipoprotein E-deficient mice with phenylhydrazine-induced anemia

Atherosclerosis

Volumn 147, Issue 1, 1999, Pages 61-68

  Paul, Antoni ^a   Calleja, Lucía ^b   Vilella, Elisabet ^a   Martínez, Roberto ^b   Osada, Jesús ^b   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Anemia; Atherosclerosis; Diet; Hemorheology; Lipoproteins; Phenylhydrazyne

Indexed keywords

ALBUMIN; APOLIPOPROTEIN E; CHOLESTEROL; GLOBIN; HEMOGLOBIN; HEMOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1; LIPOPROTEIN; PHENYLHYDRAZINE; PORPHYRIN; PROTEIN; TRIACYLGLYCEROL;

ANEMIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BLOOD RHEOLOGY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FAST PROTEIN LIQUID CHROMATOGRAPHY; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MOUSE; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; RETICULOCYTE COUNT;

EID: 0032828169     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00164-1     Document Type: Article

References (47)

1. Ross R. The pathogenesis of atherosclerosis, an update. New Engl. J. Med. 314:1986;488-500.
2. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol hemostasis. Science. 232:1986;34-47.
3. Koenig W., Ernst E. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis. 94:1992;93-107.
4. De Simone G., Devereux R.B., Chien S., Alderman M.H., Atlas S.A., Laragh J.H. Relations of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation. 81:1990;107-117.
5. Yarnell J.W.G., Baker I.A., Sweetnam P.M., Bainton D., O'Brien J.R., Whitehead P.J., Elwood P.C. Fibrinogen, viscosity and white blood cell count are major risk factors for ischaemic heart disease: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation. 83:1991;836-844.
6. Burch G.E., DePasquale N.P. The hematocrit in patients with myocardial infarction. J. Am. Med. Assoc. 180:1962;143-145.
7. Sorlie P.D., Garcia-Palmieri M.R., Costas R., Havlik R.J. Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health program. Am. Heart J. 101:1981;456-461.
8. Abu-Zeid H.A., Chapman J.M. The relation between hemoglobin level and the risk for ischemic heart disease: a prospective study. J. Chron. Dis. 29:1976;395-403.
9. Carter C.h, McGee D., Reed D., Yano K., Stemmerman G. Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. Am. Heart J. 105:1983;674-679.
10. Kannel W.B., Gordon T., Wolf P.A., McNamara P. Hemoglobin and the risk of cerebral infarction: the Framingham study. Stroke. 3:1972;409-420.
11. Böttiger L.E., Carlson L.A. Relation between serum cholesterol and triglyceride concentration and haemoglobin values in non-anaemic healthy persons. Br. Med. J. 3:1972;731-733.
12. Kochar M.S., Paka S., Kim M.J. Relation between serum cholesterol and hematocrit. J. Am. Med. Assoc. 267:1992;1071.
13. Rifkind B.M., Gale M. Hypolipidaemia in anaemia. Implications for the epidemiology of ischaemic heart disease. Lancet. 2:1967;640-642.
14. Ross R., Glomset J.A., Kariya B., Harke L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. USA. 71:1974;1207-1210.
15. Marcus A.J., Safier L.B. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J. 7:1993;516-522.
16. Santos M.T., Valles J., Aznar J., Marcus A.J., Broekman M.J., Safier L.B. Prothrombotic effects of erythrocytes on platelet reactivity. Reduction by aspirin. Circulation. 95:1997;63-68.
17. Livio M., Gotti E., Marchesi D., Mecca G., Remuzzi G., de Gaetano G. Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusion. Lancet. 2:1982;1013-1016.
18. Goldsmith H.L., Turitto V.T. Rheological aspects of thrombosis and haemostasis: basic principles and applications. Thromb. Haemost. 55:1986;415-435.
19. Reimers R.C., Sutera S.P., Joist J.H. Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. Blood. 64:1984;1200-1206.
20. Van Breugel H.H.F.I., de Groot P.G., Heethaar R.M., Sixma J.J. Role of plasma viscosity in platelet adhesion. Blood. 80:1992;953-959.
21. Clivillé X., Bofill C., Joven J., Monasterio J., Viscor G., Vernis M., Angles A., Sans T. Hemorheological, coagulative and fibrinolytic changes during autologous blood donation. Clin. Hemorrheol. Microcirc. 18:1998;265-272.
22. Meyers D.G., Strickland D., Maloley P.A., Seburg J.K., Wilson J.E., McManus B.F. Possible association of a reduction in cardiovascular events with blood donation. Heart. 78:1997;188-193.
23. Redondo P.A., Alvarez A.I., Diez C., Fernandez F., Prieto J.G. Physiological response to experimentally induced anemia in rats: a comparative study. Lab. Anim. Sci. 45:1995;578-583.
24. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P., Maeda N. Generation of mice carrying a mutant apolipoprotein E-gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:1992;4471-4475.
25. Plump A.S., Smith J.D., Hayek T. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
26. Breslow J.L. Mouse models of atherosclerosis. Science. 272:1996;685-688.
27. Zhang S.H., Reddick R.L., Burkey B., Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J. Clin. Invest. 94:1994;937-945.
28. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arter. Thromb. 14:1994;133-140.
29. Kinuta M., Matteson J.L., Itano H.A. Difference in rates of the reaction of various mammalian oxyhemoglobins with phenylhydrazine. Arch. Toxicol. 69:1995;212-214.
30. Yang C.Y., Gu Z.W., Yang H.X., Yang M., Gotto A.M. Jr, Smith C.V. Oxidative modifications of apoB-100 by exposure of low density lipoproteins to HOCL in vitro. Free Rad. Biol. Med. 23:1997;82-89.
31. Futamura Y., Matsumoto K. Characteristics of peripheral blood monocytes and bone marrow macrophages from rats treated with mitomycin C, 5-fluorouracil or phenylhydrazine. J. Toxicol. Sci. 20:1995;1-7.
32. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.
33. Paigen B., Morrow A., Holmes P.A., Mitchell D., Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:1987;231-240.
34. Simó J.M., Castellano I., Ferré N., Joven J., Camps J. Evaluation of a homogeneous assay for high density lipoprotein cholesterol: limitations in patients with cardiovascular, renal and hepatic disorders. Clin. Chem. 44:1998;1233-1241.
35. Vilella E., Joven J., Fernandez M., Vilaró S., Brunzell J.D., Olivecrona T., Bengtsson-Olivecrona G. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J. Lipid Res. 34:1993;1555-1564.
36. Wannamethee G., Shaper G. Haematocrit: relationships with blood lipids, blood pressure and other cardiovascular risk factors. Thromb. Hemost. 72:1994;58-64.
37. Turitto V.T., Weiss H.J. Red blood cells: their dual role in thrombus formation. Science. 207:1980;541-543.
38. Rojas A., Stewart F.A., Smith K.A., Soranson J.A., Randhawa V.S., Strattford M.R., Denekamp J. Effect of anemia on tumor radiosensitivity under normo- and hyperbaric conditions. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;1681-1689.
39. Koong A.C., Hirst D.G. The influence of chronic anemia on the radiosensitivity of two mouse tumors. Br. J. Cancer. 63:1991;499-502.
40. Maggio-Price L., Grossman A., Engel D., Rosse C. Altered lymphocyte populations in sphha/sphha mice with chronic hemolytic anemia. Cell Immunol. 138:1991;360-371.
41. McCormack M., Nias A.H., Smith E. Chronic anemia, hyperbaric oxygen and tumor radiosensitivity. Br. J. Radiol. 6:1990;793-800.
42. Corti M.C., Gaziano M., Hennekens C.H. Iron status and risk of cardiovascular disease. Ann. Epidemiol. 7:1997;62-68.
43. Wierenga P.K., Konings W.T. Effect of a hyperthermic treatment on the pluripotent hemopoietic stem cell in normal and anemic mice. Int. J. Hyperth. 6:1990;793-800.
44. Jain S.K., Hoochstein P. Membrane alterations in phenylhydrazyne-induced reticulocytes. Arch. Biochem. Biophys. 201:1980;683-687.
45. Chen D., Kaul D.K. Rheologic and hemodynamic characteristics of red cells of mouse, rat and humans. Biorheology. 31:1994;103-113.
46. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. New Engl. J. Med. 326:1992;242-250.
47. The EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb-IIIa receptor in high risk coronary angioplasty. New Engl J Med 1994; 330:956-961.